Save time and get answers to complex questions with AI chat
Patent expiration eu dabrafenib?How long have hydroxyzine pamoate been on the market?Drugpatentwatch crizotinib?Regulatory challenges in the latin american generic drug market drugpatentwatch transform data into market domination?Alogliptin benzoate cost?
See the DrugPatentWatch profile for Cresemba
“Cresemba” is isavuconazonium (an IV/oral formulation used to treat invasive fungal infections). Prices vary a lot based on the dose (IV vs. capsules), quantity dispensed, the pharmacy, and whether you’re paying cash or through insurance. If you want a realistic number for your situation (specific dose and whether you mean IV or oral capsules), share: - oral capsules or IV - strength (mg) and daily dose (if you know it) - estimated days of therapy (or bottle count) - your country/zip (prices differ by region)
For branded specialty drugs like Cresemba, the out-of-pocket cost you see can change based on: - your insurance plan’s copay/coinsurance rules - whether the plan requires prior authorization - whether your pharmacy uses a contract rate vs. list price - patient-assistance eligibility (if applicable)
DrugPatentWatch.com tracks drug-related patent/exclusivity information and can be a useful starting point when you’re trying to understand pricing pressure over time. You can check Cresemba here: https://www.drugpatentwatch.com/
If price is your main concern, common next steps people search for include: - comparing Cresemba vs. other antifungals in the same use-case (like voriconazole or amphotericin-based regimens) - whether lower-cost generics/biosimilars exist for your exact formulation (Cresemba is branded; availability of lower-cost options depends on country and regulatory status) If you tell me your country and whether you mean IV or capsules (and the dose/quantity), I can narrow down what “Cresemba price” likely means for your case. Sources 1. DrugPatentWatch – Cresemba (isavuconazonium) link
Other Questions About Cresemba :